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Corticotropin-releasing factor (CRF) stimulates the synthesis and release of adrenocorticotropin in the ante- 
rior pituitary and may help maintain fluid and electrolyte balance. ‘Salt-loaded’ rats had an increase in CRF 
mRNA in hypothalamic magnocellular neurons of the paraventricular and supraoptic nuclei and a decrease 
in message in the parvocellular paraventricular neurons. After salt-loaded rats were adrenalectomized, CRF 
mRNA increased in the parvocellular cells. In contrast to salt loading, water deprivation lead to a decrease 
in CRF mRNA in magnocellular and parvocellular neurons. These results show that CRF synthesis within 
separate populations of hypothalamic neurons is regulated differently under various conditions. 
(Puraventriculur nucleus, Supraoptic nucleus) 
1. INTRODUCTION 
Fluid and electrolyte balance is maintained 
through a complex interplay of neuronal, hor- 
monal, and osmotic signals. The adrenals are 
essential for this regulation [ 11. Pituitary 
adrenocorticotropin hormone (ACTH) stimulates 
adrenal glucocorticoid synthesis while the amino 
terminus of the ACTH precursor, pro- 
opiomelanocortin (POMC), may stimulate 
mineralocorticoid production [2,3]. The synthesis 
of POMC in the anterior pituitary is controlled, in 
part, by corticotropin-releasing factor (CRF) [4]. 
Two major sites of CRF synthesis are the 
paraventricular (PVN) and supraoptic (SON) 
nuclei of the hypothalamus [5-9). Within these 
nuclei, CRF is colocalized with oxytocin in about 
one-third of the magnocellular neurons [ 10,111 and 
with vasopressin in most of the parvocellular 
neurons of the PVN [ 12-141. The function of the 
CRF synthesized by the oxytocin neurons is 
unknown. Presumably, the parvocellular CRF 
neurons, which project to the median eminence 
[ 15,161, are normally responsible for stimulating 
ACTH production in the anterior pituitary [4,17]. 
Adrenalectomy Hybridization Pituitary 
Consistent with this, CRF and CRF mRNA in- 
crease in the parvocellular neurons after adrenalec- 
tomy and hypophysectomy [7,18-201. 
To gain a better understanding of the possible 
role of CRF in maintaining fluid and electrolyte 
balance, we examined the effect of giving rats 
saline or nothing to drink on hypothalamic CRF 
mRNA levels. These observations were made using 
in situ hybridization histochemistry with an 35S- 
labeled synthetic oligodeoxynucleotide probe [20]. 
2. MATERIALS AND METHODS 
Male, Sprague-Dawley rats (175-250 g, NIH) 
were housed with a 12 h on, 12 h off lighting 
schedule. Eight rats were given food and 2% NaCl 
(‘salt-loaded’) for 1 week and four rats were denied 
water for 3 days (‘dehydrated’). We have shown 
previously that adrenalectomy leads to increased 
CRF mRNA levels in the parvocellular division of 
the PVN [20], so we also adrenalectomized four 
rats under ether anesthesia and salt-loaded them 
for 1 week. 
The rats were killed under ether anesthesia and 
the brains removed, frozen on dry ice, and stored 
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at -80°C. Frozen sections (12pm) were then cut 
and thaw-mounted onto twice gelatin-coated 
slides. To avoid variation in cell distribution, only 
those sections containing the PVN and SON 
1.8-l .9 mm caudal to the level of the bregma (see 
fig.3 of [7]) were used in this study. 
The tissues were processed and hybridized as 
described [20] with minor modifications. Briefly, 
the sections were warmed at room temperature for 
10 min and then placed in 0.25% acetic anhydride 
in 0.1 M triethanolamine/0.9% NaCl, pH 8, for 
10 min at room temperature. They were then 
passed through a graded series of ethanols, 
chloroform, and ethanol before air-drying. Subse- 
quently, 0.5-2.0 x lo6 dpm of the CRF probe in 
45 ~1 hybridization buffer (containing 0.66 M 
sodium and 50% formamide) were applied to each 
section. The hybridizations were performed for 
22-24 h at room temperature or 37°C and the sec- 
tions then were washed in four 15 min rinses in 2 
x SSC (1 x SSC = 0.15 M NaCl, 0.015 M sodium 
citrate, pH 7.2)/50% formamide at 40°C. After 
two 1 h rinses in 2 x SSC at room temperature and 
two rapid water dips to remove salts, the sections 
were dried. They were then apposed to NTB3 (1: 1 
with water, Kodak) nuclear emulsion-coated 
coverslips or dipped directly into the emulsion. 
The autoradiograms were developed after 2-6 
weeks and the tissues stained with cresyl violet. 
The CRF probe was complementary to the 
mRNA coding for amino acids 22-37 of CRF pro- 
per [21]. Details of its preparation, labeling, and 
specificity of hybridization have been described 
[20]. The specific activities of the probe used here 
were 3000-8000 Ci/mmol. 
3. RESULTS 
In agreement with our previous study [20], CRF 
mRNA in control animals was found in the par- 
vocellular neurons of the PVN (fig.lA). However, 
when the hybridizations were performed at 37”C, 
labeling was also seen over magnocellular neurons 
in the same pattern of distribution as oxytocin 
neurons [22,23], surrounding the core of 
vasopressin neurons and in the ventral aspects of 
the PVN (cf. figs 1A and 2A) and in the dorsal 
SON (not shown). In these sections, cells contain- 
ing CRF mRNA were also observed in the central 
nucleus of the amygdala and neocortex, in agree- 
ment with immunocytochemical studies [5,6,8,9]. 
After salt loading, the labeling decreased in the 
parvocellular portion of the PVN (figs lB,2C) and 
increased in the magnocellular cells (fig.lB). The 
Fig.1. CRF mRNA in the PVNs from control (A) and salt-loaded (B) rats detected using an “S-labeled probe and in 
situ hybridization histochemistry. The hybridization was performed at room temperature. In these dark-field 
photomicrographs, the autoradiographic grains appear white. The parvocellular region is labeled in the control and has 
decreased labeling after salt loading (outlined). The hollow stars are placed over the vasopressin cores and solid stars 
over the regions which contain oxytocin magnocellular neurons (which also encircle the vasopressin core in B). Note 
the increased CRF mRNA detected in the oxytocin areas after salt loading. V is the third ventricle. Bar, 100 /tm. 
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Fig.2. CRF mRNA in the PVNs from control (A), dehydrated (B), salt-loaded (C), and salt-loaded adrenalectomized 
(D) rats. The hybridizations were performed at 37°C. The dehydrated rat had a genera1 decrease in CRF mRNA while 
the salt-loaded rat had a selective decrease in CRF mRNA in the parvocellular (p) PVN. There was also a slight increase 
in CRF mRNA over the magnocellular (m), oxytocin neurons which is not evident photographically (see fig.l). 
Adrenalectomy in the salt-loaded rat caused an increase in the parvocellular PVN to above control levels. V is the third 
ventricle and the star indicates the vasopressin neuron-containing core of the PVN. Bar, 100,~m. 
labeling over the dorsal SON also increased after 
salt loading (not shown). In the salt-loaded 
adrenalectomized animals, the labeling over both 
the parvocellular and magnocellular cells was 
greater than controls (fig.2D). Finally, in the 
dehydrated rats there was a decrease in labeling 
over both cell types in the PVN (fig.2B) and SON. 
4. DISCUSSION 
At present, the factors which eventually in- 
fluence CRF synthesis and the pathways through 
which they are effected are only partly understood 
[17]. Salt loading [24] and, to a greater extent, 
dehydration [25] lead to increases in plasma 
osmolality. This may be the common stimulus that 
leads to decreased CRF mRNA in the parvocellular 
PVN. It is possible that these effects are mediated 
through a change in adrenergic tone [26]. Ap- 
parently, this is not a powerful enough stimulus to 
override the effect of adrenalectomy on CRF 
mRNA levels there (at least when paired with salt 
loading). 
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On the other hand, the opposite effects of salt 
loading and dehydration on magnocellular CRF 
mRNA levels would suggest at least two different 
mechanisms are involved. Salt loading is accom- 
panied by only a modest increase in plasma 
osmolality whereas dehydration produces a large 
increase in addition to a profound contraction of 
the extracellular fluid space [24,25]. These two 
manipulations potentially influence many com- 
ponents involved in maintaining fluid and elec- 
trolyte homeostasis, including peripheral and brain 
renin-angiotensin systems, vasopressin release, 
volume receptors, baroreceptors, osmoreceptors, 
and receptors for mineralocorticoids [27-321. 
These components, in turn, relay information to 
the PVN through pathways originating in various 
brainstem nuclei (e.g. nucleus of the solitary tract, 
Al cell group) and circumventricular areas (e.g. 
subfornical organ, anteroventral third ventricle) 
[29,33]. Furthermore, there also exists the 
possibility for interactions between peptidergic 
neurons within the PVN. For example, Plotsky 
[34] has shown that intraventricular injections of 
CRF reduced portal plasma levels of vasopressin 
and oxytocin. In view of these complexities, it is, 
perhaps, not surprising that salt loading and 
dehydration resulted in different effects. 
The role of CRF in the oxytocin neurons is 
unknown. It may participate in local regulation 
within the PVN and SON as discussed above. CRF 
may also help regulate secretion of oxytocin and 
vasopressin from axon terminals in the posterior 
pituitary, as has been postulated for dynorphin 
[35]. Finally, CRF may reach the anterior pituitary 
via the portal circulation along with oxytocin and 
vasopressin [36-391, to stimulate ACTH synthesis 
and release. Although portal plasma levels of CRF 
do not increase in response to hemorrhagic stress 
when release from the PVN is blocked [40], the 
situation could well be different after salt loading. 
These and other questions, such as the control of 
CRF synthesis during pregnancy and lactation, 
should be amenable to study. 
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